Beijing Ql Biopharmaceutical Co.,ltd
Clinical trials sponsored by Beijing Ql Biopharmaceutical Co.,ltd, explained in plain language.
-
First human tests for new Weight-Loss injection
Disease control CompletedThis was an early-stage study to check the safety and drug levels of a new injection called ZT002 in people with overweight or obesity. Twenty-eight adults received either the drug or a placebo (dummy injection) in increasing doses. The main goal was to see how well the body hand…
Phase: PHASE1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First human test for new Weight-Loss pill begins
Disease control CompletedThis was an early-stage study to check the safety and basic effects of a new oral medication called ZT006, which is being developed to help manage weight. It involved 94 healthy adults who were overweight or obese. Researchers tested single and multiple doses to see how the body …
Phase: PHASE1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New injection shows promise in weight loss trial
Disease control CompletedThis study tested whether a new injectable medication called ZT002 helps people with overweight or obesity lose weight. Over 300 adults received either the medication or a placebo (dummy injection) for 24 weeks. The main goal was to see how much their body weight changed from the…
Phase: PHASE2 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC